by rdbiomed | Oct 27, 2017 | Company News
A three-month study into how Peptest can be used to diagnose gastro-oesophageal reflux disease has begun in China, following an official launch in August. The launch took place at the ‘Normal range reference of Chinese PGI research conference’ on 12 August 2017 at the...
by rdbiomed | Oct 20, 2017 | Company News
We’d like to introduce you to members of the RD Biomed and Peptest team… let’s meet Adrian. Versatile Adrian joined the company in April and provides administration support as well as help in the Peptest laboratories. Adrian explains: “My role is in...
by rdbiomed | Sep 25, 2017 | Company News
RD Biomed and the Peptest team headed to the OESO 14th World Conference (Global Perspective of Esophageal Disease) in Geneva in early September. OESO, with more than 14,000 members from 85 countries, is an international assembly of the world’s leading specialists who...
by rdbiomed | Aug 16, 2017 | Company News
We’re pleased to announce that we have officially registered Peptest – a device for the diagnosis of reflux disease – with the US Food and Drug Administration (FDA). Peptest is a non‑invasive, diagnostic medical device that contains antibodies for detecting the...
by rdbiomed | Jun 15, 2017 | Company News
Let us introduce to you the Peptest Cube – a small and easy to use electronic lateral flow device reader that lets medical professionals quickly measures the concentration of Pepsin in saliva samples. The Cube is suitable for use in the quantitative and...
by rdbiomed | Mar 6, 2017 | Company News
Imedex, Peptest’s exclusive distributor for the Czech Republic and Slovakia, has unveiled exciting plans to host its first ‘Peptest Day’ in April. The knowledge-sharing event will take place in Prague on 20 April with Professor Peter Dettmar heading over from the UK...
Recent Comments